Radiation therapy for hard-to-reach lung tumors
Part of Cancer, Lungs & breathing clinical trials.
This study tests a precise type of radiation called SBRT for small lung cancers located near the center of the chest, close to important structures like the windpipe or heart. The goal is to see if this treatment can safely target the tumor while sparing healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a lung cancer that is small (5 cm or less) and has not spread to lymph nodes or other parts of the body.
- Your tumor must be in a central area of the chest, very close to the windpipe, heart, or major blood vessels.
- You must be able to have a bronchoscopy (a scope through the mouth into the lungs) to place tiny markers (fiducials) near the tumor, which help guide the radiation.
- You must be considered unable to have surgery, decline surgery, or be at high risk for surgery.
- You must not have had radiation to the chest before that would overlap with this treatment.
- You must not have certain lung conditions like interstitial lung disease or active connective tissue diseases (e.g., lupus, scleroderma).
- You must not be pregnant or breastfeeding, and if you can have children, you must agree to use contraception.
- You must be able to lie flat for about 45-60 minutes during each treatment session.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special type of focused radiation therapy can effectively treat advanced non-small cell lung cancer (the most common type) as an upfront treatment. It may help patients avoid or delay chemotherapy while controlling their cancer.
This trial tests a newer, more precise way of giving radiation for lung cancer tumors that are near the center of the chest. The goal is to see if using a smaller treatment area can reduce side effects while still killing the cancer.
This trial tests a personalized radiation treatment called SBRT for early-stage non-small cell lung cancer that is located in the outer part of the lung and cannot be removed with surgery. The goal is to see if this approach works well for people who cannot have surgery or choose not to.
This trial studies a precise, high-dose radiation technique (SBRT) to treat tumors in the lungs. It may help control cancer in people who either have early-stage lung cancer that is not fully operable or have limited lung metastases from other cancers.
This trial studies a focused, high-dose radiation treatment called SBRT for lung tumors that are hard to operate on, including very central tumors near major airways or organs. It may help people control tumor growth while limiting radiation exposure to nearby critical structures.
This trial studies how safe and effective a type of focused radiation called SBRT is for cancer tumors in certain chest locations. It’s meant for people whose tumor is small (up to 5 cm) and who don’t have widespread, uncontrolled spread.
Hear when a new Nonsmall Cell Lung Cancer Stage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.